Positron emission tomography in lung cancer

被引：54

作者：

Shon, IH ^{[1
]}

O'Doherty, MJ ^{[1
]}

Maisey, MN ^{[1
]}

机构：

[1] St Thomas Hosp, Clin PET Ctr, London, England

来源：

SEMINARS IN NUCLEAR MEDICINE | 2002年 / 32卷 / 04期

关键词：

D O I：

10.1053/snuc.2002.126059

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Carcinoma of the lung is one of the most frequent malignancies and a major cause of mortality. The use of positron emission tomography (PET) has been extensively investigated in patients with carcinoma of the lung and has established clinical utility and cost-effectiveness in characterization of solitary pulmonary nodules and preoperative staging of carcinoma of the lung. Evolving applications in carcinoma of the lung include detection of recurrence, assessment of treatment response, radiotherapy planning, and prognosis. In addition, there is developing interest in combined anatomic/metabolic imaging and new tracer techniques, in particular gene expression imaging. This review aims to present existing data supporting the use of PET in carcinoma of the lung and to explore the evolving indications and future prospects of PET and lung cancer. Copyright 2002, Elsevier Science (USA). All rights reserved.

引用

页码：240 / 271

页数：32

共 303 条

[1]

ABDELDAYEM HM, 1994, EUR J NUCL MED, V21, P57

[2] CLINICAL-ASSESSMENT OF THERAPEUTIC EFFECTS ON CANCER USING F-18 2-FLUORO-2-DEOXY-D-GLUCOSE AND POSITRON EMISSION TOMOGRAPHY - PRELIMINARY-STUDY OF LUNG-CANCER [J].